Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Vasiliki Metaxa‐Mariatou"'
Autor:
Mustafa Ozdogan, Eirini Papadopoulou, Vasiliki Metaxa-Mariatou, George Kapetsis, Angeliki Meintani, Chrysiida Florou-Chatzigiannidou, Akin Yildiz, Muharrem Okan Cakir, Onder Kirca, George Nasioulas
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Predictive biomarkers are necessary for the identification of immunotherapy-responsive patients. Tumor mutation burden (TMB), as determined by next-generation sequencing (NGS), and PD-L1 expression, as evaluated by Immunohistochemistry (IHC), are the
Externí odkaz:
https://doaj.org/article/e74dcadbd5e740dbb31fb48151687675
Autor:
Aikaterini Tsantikidi, Eirini Papadopoulou, Vasiliki Metaxa-Mariatou, George Kapetsis, Georgios Tsaousis, Angeliki Meintani, Chrysiida Florou-Chatzigiannidou, Maria Gazouli, Christos Papadimitriou, Eleni Timotheadou, Athanasios Kotsakis, Anastasios Boutis, Ioannis Boukovinas, Eleftherios Kampletsas, Loukas Kontovinis, Elena Fountzilas, Charalampos Andreadis, Charisios Karanikiotis, Dimitrios Filippou, Georgios Theodoropoulos, Mustafa Özdoğan, George Nasioulas
Publikováno v:
Diagnostics, Vol 13, Iss 18, p 2962 (2023)
Several tumor types have been efficiently treated with PARP inhibitors (PARPis), which are now approved for the treatment of ovarian, breast, prostate, and pancreatic cancers. The BRCA1/2 genes and mutations in many additional genes involved in the H
Externí odkaz:
https://doaj.org/article/d2ca410e5d3c42a1ae693c3b0eb61e8b
Autor:
Eirini Papadopoulou, Nikolaos Tsoulos, Katerina Tsantikidi, Vasiliki Metaxa-Mariatou, Pinelopi Eleftheria Stamou, Athina Kladi-Skandali, Evgenia Kapeni, Georgios Tsaousis, George Pentheroudakis, Dimitrios Petrakis, Dimitra Ioanna Lampropoulou, Gerasimos Aravantinos, Ioannis Varthalitis, George Kesisis, Ioannis Boukovinas, Pavlos Papakotoulas, Nikolaos Katirtzoglou, Elias Athanasiadis, Flora Stavridi, Christos Christodoulou, Anna Koumarianou, Yeşim Eralp, George Nasioulas
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0226853 (2019)
BackgroundAnalysis of circulating tumor nucleic acids in plasma of Non-Small Cell Lung Cancer (NSCLC) patients is the most widespread and documented form of "liquid biopsy" and provides real-time information on the molecular profile of the tumor with
Externí odkaz:
https://doaj.org/article/d6673b33e83343bba170e059cedcb097
Autor:
Eirini Papadopoulou, Nikolaos Tsoulos, Vasiliki Metaxa-Mariatou, Aikaterini Tsantikidi, Georgios Kapetsis, Chrysiida Florou-Chatzigiannidou, Sonia Maravelaki, Evgenia Bourkoula, Dimitrios Fotiou, Georgios Tsaousis, Nikolaos Touroutoglou, Dimitrios Trafalis, Ioannis Boukovinas, Ioannis Varthalitis, Zacharenia Saridaki, Charalampos Zoublios, Eleni Galani, George Papatsibas, Christos Papadimitriou, Tania Zlatintsi, Polixenia Iorga, Bülent Orhan, Sualp Tansan, Tahsin Özatlı, George Nasioulas
Publikováno v:
Cancer Research. 82:P5-13
Background: Comprehensive tumor analysis by Next Generation Sequencing (NGS) is imperative for targeted and immunotherapy related biomarkers’ analysis in metastatic breast cancer enabling personalization of cancer treatment in these patients. In pa
Autor:
Nikolaos Tsoulos, Sualp Tansan, Georgios N. Tsaousis, Aikaterini Tsantikidi, Dimitrios Fotiou, Bülent Orhan, Achilleas Adamidis, Eleni Galani, George Lypas, Vasiliki-Metaxa Mariatou, Evgenia Bourkoula, George Nasioulas, Ioannis Boukovinas, Okan Çakır, Dimitrios T. Trafalis, Evgenia Kapeni, Paraskevas Kosmidis, Mustafa Ozdogan, Eirini Papadopoulou, Onder Kirca, Tahsin Özatlı, Athanasios Fassas, Georgios Kapetsis, Nikolaos Touroutoglou
Publikováno v:
BMC Medical Genomics, Vol 14, Iss 1, Pp 1-21 (2021)
BMC Medical Genomics
BMC Medical Genomics
Background Tumor molecular profile analysis by Next Generation Sequencing technology is currently widely applied in clinical practice and has enabled the detection of predictive biomarkers of response to targeted treatment. In parallel with targeted
Autor:
Özdoğan, Mustafa, Papadopoulou, Eirini, Tsoulos, Nikolaos, Tsantikidi, Aikaterini, Vasiliki-Metaxa Mariatou, Tsaousis, Georgios, Kapeni, Evgenia, Bourkoula, Evgenia, Fotiou, Dimitrios, Kapetsis, Georgios, Boukovinas, Ioannis, Touroutoglou, Nikolaos, Fassas, Athanasios, Adamidis, Achilleas, Kosmidis, Paraskevas, Trafalis, Dimitrios, Galani, Eleni, Lypas, George, Orhan, Bülent, Sualp Tansan, Özatlı, Tahsin, Onder Kırca, Çakır, Okan, Nasioulas, George
Additional file 1: Table S1. Title: Genomic Regions and fusions analyzed with the 24 and 50 gene panels. Additional file 2: Table S2. Title: Gene alterations detected by the 161 gene panel. Description: The frequency of the different mutation types (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::046c4e863d2d5d6e1474f1e06be431f7
Autor:
Aikaterini Tsantikidi, Nikolaos Tsoulos, Georgios Kapetsis, Nikolaos Touroutoglou, Evgenia Kapeni, Eirini Papadopoulou, George Lypas, Vasiliki Metaxa-Mariatou, Dimitrios Fotiou, George Tsaousis, Evgenia Bourkoula, Onder Kirca, George Nasioulas, Athanasios Fassas, Okan Çakır, Tahsin Özatlı, Tansan Sualp, Bülent Orhan, Eleni Galani, Dimitrios T. Trafalis, Mustafa Ozdogan, Achilleas Adamidis, Ioannis Boukovinas, Paraskevas Kosmidis
Background: Tumor molecular profile is of great importance for the detection of biomarkers of response to targeted treatment due to the increased availability, with concomitant reduction of cost, of Next Generation Sequencing technology (NGS). In par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dac406df53df68253d90159c5f777c5a
https://doi.org/10.21203/rs.3.rs-96233/v1
https://doi.org/10.21203/rs.3.rs-96233/v1
Autor:
George Nasioulas, Angeliki Tsirigoti, Nikolaos Tsoulos, Eugenia Bourkoula, Angela Apessos, Georgia Pepe, Eirini Papadopoulou, Konstantinos Agiannitopoulos, Georgios N. Tsaousis, Chrisoula Efstathiadou, Vasiliki Metaxa-Mariatou
Publikováno v:
World Journal of Gastrointestinal Oncology
Gastrointestinal malignancies are among the leading causes of cancer-related deaths worldwide. Like all human malignancies they are characterized by accumulation of mutations which lead to inactivation of tumor suppressor genes or activation of oncog
Autor:
Nikolaos Tsoulos, P. Papakotoulas, George Nasioulas, Evgenia Kapeni, Pinelopi Eleftheria Stamou, Vasiliki Metaxa-Mariatou, Dimitra Ioanna Lampropoulou, George Kesisis, Katerina Tsantikidi, Christos Christodoulou, Dimitrios Petrakis, Georgios N. Tsaousis, Yesim Eralp, Ioannis Boukovinas, Eirini Papadopoulou, Gerasimos Aravantinos, George Pentheroudakis, Flora Stavridi, Ioannis Varthalitis, Nikolaos Katirtzoglou, Anna Koumarianou, Elias Athanasiadis, Athina Kladi-Skandali
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0226853 (2019)
PLoS ONE
PLoS ONE
BackgroundAnalysis of circulating tumor nucleic acids in plasma of Non-Small Cell Lung Cancer (NSCLC) patients is the most widespread and documented form of "liquid biopsy" and provides real-time information on the molecular profile of the tumor with
Autor:
Vasiliki Metaxa-Mariatou, Jubrail Dahabreh, Angela Apessos, Aggeliki Rapti, Vasileios Karavasilis, N Papageorgiou, Charalampos Zoublios, Mina Gaga, P. Zarogoulidis, Dimitrios Veldekis, George Nasioulas, Gerasimos Aravantinos, Stylianos Kakolyris, Konstantinos Zarogoulidis, Dimitrios Kasarakis, Napoleon Karagiannidis, Fotis Vlastos, Angeliki Tsirigoti, Eirini Papadopoulou, Konstantinos Agiannitopoulos, Nikolaos Tsoulos
Publikováno v:
Oncology Letters. 10:2176-2184
It has been reported that certain patients with non-small-cell lung cancer (NSCLC) that harbor activating somatic mutations within the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene may be effectively treated using targete